Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/13/14 20:22 | 2/7/14 | GALE | Health | Drug | Pharmaceutical Preparations | Nisi Rudolph | OR | D | P | 99 | 4.94 | 33 | 20 | 571 | 24 | D | 295 | 137 | 121 | 77 | -13 | -29 | 3 | -12 | -14 | -10 | -28 | -47 | -39 | -63 | |
12/7/11 16:39 | 12/7/11 | GALE | Health | Drug | Pharmaceutical Preparations | Lee Kwang | OR | O | Principa | P | 3 | 0.6000 | 0 | 5 | New | 5 | D | -79 | -86 | -54 | -46 | -33 | -23 | 6 | -21 | -8 | -21 | -8 | 122 | 129 | 268 |
12/7/11 16:16 | 12/7/11 | GALE | Health | Drug | Pharmaceutical Preparations | Ahn Mark J | OR | DO | P,CEO | P | 7 | 0.6590 | 0 | 10 | 100 | 20 | D | -79 | -86 | -54 | -46 | -33 | -23 | 6 | -21 | -8 | -21 | -8 | 122 | 129 | 268 |
4/20/11 11:09 | 4/20/11 | RXII | Health | Drug | Pharmaceutical Preparations | Ahn Mark J | MA | DO | P,CEO | P | 10 | 0.9500 | 0 | 10 | New | 10 | D | ||||||||||||||
7/12/10 15:23 | 7/9/10 | RXII | Health | Drug | Pharmaceutical Preparations | Beerman Noah D | MA | DO | CEO,P | P | 22 | 2.23 | 0 | 10 | 185 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |